Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort.
about
Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric ComplaintsMarine fatty acid intake is associated with breast cancer prognosisOmega-3 fatty acids for breast cancer prevention and survivorshipStabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerThe potential health effects of dietary phytoestrogensTreatment of mice with 2,3,7,8-Tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung.Dietary conjugated linoleic acid and long-chain n-3 fatty acids in mammary and prostate cancer protection: a review.Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies.Cod liver oil supplement consumption and health: cross-sectional results from the EPIC-Norfolk cohort study.ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancerThe role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancerBlack cohosh and breast cancer: a systematic review.Soy, red clover, and isoflavones and breast cancer: a systematic reviewThe Impact of Nutrition on the Development and Prognosis of Breast Cancer.A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patientsEstrogen action and prostate cancer.Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studiesLong-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle studyα-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways.Use of glucosamine and chondroitin in relation to mortalityAssociation between use of specialty dietary supplements and C-reactive protein concentrations.Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis.Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort.Use of glucosamine and chondroitin supplements and risk of colorectal cancer.Omega-3 fatty acids for the prevention of breast cancer: an update and state of the science.Specialty supplement use and biologic measures of oxidative stress and DNA damage.What are the real risks for breast cancer?Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies.The emerging harm of antioxidants in carcinogenesis.An Evidence-Based Systematic Review of Black cohosh (Cimicifuga racemosa, Actaea racemosa) by the Natural Standard Research Collaboration.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.Early Life Residence, Fish Consumption, and Risk of Breast Cancer.Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients.The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study.Phytotherapy and Nutritional Supplements on Breast CancerRisk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavonesRelations of omega-3 and omega-6 intake with mammographic breast density.Use of isoflavone supplements is associated with reduced postmenopausal breast cancer riskEffects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation
P2860
Q21284761-370E1065-476E-4905-A3DE-A066A6E17E63Q24597210-01199ECC-D2E3-4454-9919-BDBE1581FB37Q28080498-141DF526-ED2A-4F98-8139-0A8553FCF22EQ28304230-B8E71020-F9F4-427B-A271-60527EDE3676Q33676455-9F05914C-1094-445F-ADB5-6E6E06460ED9Q33798656-A94B49AE-4E18-4DA4-BBBC-94C739F8D946Q34200763-0518BFB8-AA2F-454F-A0B3-13AE67263D64Q34282204-CE54EB38-79B3-43A5-9D8D-0B046ED5B6ADQ34411678-9D5FAC21-6176-4D45-8510-210B896183A6Q34428959-D1258D16-D935-4A81-B6D3-C9009736E604Q34578129-D80DDEEE-947F-4C66-BA97-E148DE986C2FQ34601209-FF3AD3AE-860E-49B9-8B30-A094884B3E54Q34658148-8DD0C346-A8DB-487D-A199-C516ED9D726CQ34791098-CBDCAB03-E078-4DFF-9291-15986F61ABEFQ35092002-DDCF5147-7C3E-4F49-82A8-746EA785D071Q35099011-444C0D14-14D7-4D6F-BFF0-18A4E9241466Q35107003-BFF3E7B1-6C97-49E1-85AC-02255178A771Q35547580-6B7447A9-13C6-4835-8809-A61B0C35EF3AQ35965040-BF48E432-EED6-4319-9C8E-D6FA591691D0Q36570336-7AB50EF8-799C-41F5-B159-BCB5C6CA4F71Q36606633-54805ADF-7402-4FF9-8A30-2E0829552274Q36680139-4C47AA9F-7C7F-4D56-8676-8EA5C009B27CQ36782159-4C91EB12-79AF-4F46-A13D-FF9972BFD875Q36787916-C3DC34B0-2FB7-4BE2-925B-83EA65F7C048Q36900371-1516C611-DA9C-4BF5-B1A4-70BE84F83538Q37190731-04FE042F-B2BA-4187-8C84-AE9CE2375A19Q37512685-C31DB81A-C36C-436C-88F5-9563567F4C93Q37964796-4E520A20-2306-43D2-B38C-121A2FDBFCC5Q38010559-DC65422B-2D5C-4E6A-8641-C34704024E4AQ38014532-E3F30541-04E8-491D-B711-974184F56AEBQ38242928-088D7B5E-00FF-4F81-8E78-A262E98BD677Q38557891-40867240-F516-4FAA-B66E-F8C6E4EDB675Q39265056-BE16DC3A-5B8A-4824-A8D3-74837014F0D6Q40095243-BC22FDB0-61AF-4292-8035-5944E5B4EBCFQ40137807-01E39341-B3D8-491D-A64D-5B58F51026A6Q41463405-81FED74A-636B-4B34-B36B-B5436652A865Q47157326-DFA40E1A-2857-41BE-8830-6B5A2EB19680Q51760105-C5AD49E6-6510-4F7B-903A-D50F95E24038Q56672310-FC736E66-4F0B-4393-B8DD-DFA6E73969F4Q58726869-E85B42D4-93C7-4D44-9406-7244FBD45C96
P2860
Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Specialty supplements and brea ...... And Lifestyle (VITAL) Cohort.
@ast
Specialty supplements and brea ...... And Lifestyle (VITAL) Cohort.
@en
Specialty supplements and breast cancer risk in the VITamins And Lifestyle
@nl
type
label
Specialty supplements and brea ...... And Lifestyle (VITAL) Cohort.
@ast
Specialty supplements and brea ...... And Lifestyle (VITAL) Cohort.
@en
Specialty supplements and breast cancer risk in the VITamins And Lifestyle
@nl
prefLabel
Specialty supplements and brea ...... And Lifestyle (VITAL) Cohort.
@ast
Specialty supplements and brea ...... And Lifestyle (VITAL) Cohort.
@en
Specialty supplements and breast cancer risk in the VITamins And Lifestyle
@nl
P2093
P2860
P1476
Specialty supplements and brea ...... And Lifestyle (VITAL) Cohort.
@en
P2093
Emily White
Johanna W Lampe
Ruth E Patterson
Theodore M Brasky
P2860
P304
P356
10.1158/1055-9965.EPI-10-0318
P50
P577
2010-07-01T00:00:00Z